Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Milton
Clinical trial register · Australia

Clinical Trials in Milton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Milton

10 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Canberra, Liverpool, Chelmer, Chermside, Ipswich, Milton, Adelaide, Bedford Park
2026-05-11
Recruiting
Amgen
Phase 3
12,800
Charlestown, Darlinghurst, St Leonards, Auchenflower, Herston, Milton, Woolloongabba, Bedford Park
2025-07-25
Recruiting
Takeda
Phase 3
347
Liverpool, Milton, Box Hill, Clayton, St Albans
2025-07-15
Recruiting
Marea Therapeutics
Phase 2
316
Canberra, Kanwal, Merewether, Miranda, Wollongong, Herston, Milton, Leabrook
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Recruiting
Colorado Prevention Center
Phase 3
5,200
Blacktown, Milton, Elizabeth Vale, Melbourne, Mulgrave, Adelaide
2024-01-17
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Botany, New Lambton Heights, Auchenflower, Milton, Woolloongabba, Adelaide, Bedford Park, Leabrook
2021-11-23
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Chermside, Milton, Taringa, Hobart, Geelong, Heidelberg, Melbourne
2019-09-20
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/milton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Milton.

How many clinical trials are recruiting in Milton?

6 of the 10 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milton), 10 studies
PhaseStudiesRecruitingShare
Phase 39590%
Phase 21110%

Most active sponsors

Lead sponsors with the most studies (Milton)
Lead sponsorStudiesRecruiting
Amgen22
Novartis Pharmaceuticals20
Novo Nordisk A/S21
Applied Therapeutics, Inc.10
Colorado Prevention Center11
Marea Therapeutics11
Takeda11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.